Fong, Michael
University of Southern California
2 papers on CoChatORCID 0000-0002-0874-7059
Most cited papers
- Verified
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: A multicenter randomized trial
Nassif, M. E., Windsor, S. L., Borlaug, B. A., Kitzman, D. W., Shah, S. J., Tang, F., Khariton, Y., Malik, A. O., Khumri, T., Umpierrez, G., et al. (2021) · Nature Medicine
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 618
- Verified
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Nassif, M. E., Windsor, S. L., Tang, F., Khariton, Y., Husain, M., Inzucchi, S. E., McGuire, D. K., Pitt, B., Scirica, B. M., Austin, B., et al. (2019) · Circulation
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 424
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free